Affiliations 

  • 1 Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan
  • 2 Institute of Population Health Science, National Health Research Institutes, Miaoli, Taiwan
  • 3 Department of Internal Medicine, National Taiwan University College of Medicine, Taipei City, Taiwan
  • 4 Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan
  • 5 Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
  • 6 Department of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Malaysia
  • 7 University of the East Ramon Magsaysay Memorial Medical Center Inc, Quezon City, Philippines
  • 8 Department of Internal Medicine, University of Medicine and Pharmacy, Hue University, Hue, Vietnam
  • 9 Division of Cardiology, Cardiovascular Hospital, Yonsei Health System, Seoul, Korea
  • 10 Faculty of Cardiology Service, Hanyang University Medical Center, Seoul, Korea
  • 11 Fatima Memorial Hospital, Lahore, Pakistan
  • 12 Section of Cardiology, Department of Medicine, Medical Center Manila, Manila, Philippines
  • 13 Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia-National Cardiovascular Center, Jakarta, Indonesia
  • 14 MIOT International Hospital, Chennai, India
  • 15 Cardiology Division, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
  • 16 Department of General Medicine, Tan Tock Seng Hospital, Singapore, Singapore
  • 17 Division of Nephrology, Department of Medicine, Yong Loo Lin School of Medicine, Singapore, Singapore
  • 18 Faculty of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia
  • 19 Indian Society of Hypertension, King George's Medical University, Lucknow, India
  • 20 Divisions of Hypertension and Heart Failure, Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
  • 21 Department of Hypertension, Centre for Epidemiological Studies and Clinical Trials, the Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
J Clin Hypertens (Greenwich), 2020 03;22(3):391-406.
PMID: 31841279 DOI: 10.1111/jch.13758

Abstract

Since noninvasive central blood pressure (BP) measuring devices are readily available, central BP has gained growing attention regarding its clinical application in the management of hypertension. The disagreement between central and peripheral BP has long been recognized. Some previous studies showed that noninvasive central BP may be better than the conventional brachial BP in association with target organ damages and long-term cardiovascular outcomes. Recent studies further suggest that the central BP strategy for confirming a diagnosis of hypertension may be more cost-effective than the conventional strategy, and guidance of hypertension management with central BP may result in less use of medications to achieve BP control. Despite the use of central BP being promising, more randomized controlled studies comparing central BP-guided therapeutic strategies with conventional care for cardiovascular events reduction are required because noninvasive central and brachial BP measures are conveniently available. In this brief review, the rationale supporting the utility of central BP in clinical practice and relating challenges are summarized.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.